Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its Esprit BTK drug-eluting stent.

"Abbott touts long-term efficacy for dissolvable Esprit BTK stent" was originally created and published by Medical Device ...

A large-scale, randomized trial of the orbital atherectomy system Abbott picked up last year failed to show that it could ...

Growing cases of coronary artery diseases propel the coronary stent market in the United States. Favorable government support ...

T o address chronic limb-threatening ischemia—a serious condition in which patients have majorly blocked blood flow to their ...

Routine use of an orbital atherectomy device to remove calcium from severely blocked coronary arteries before patients ...

For patients with severely calcified coronary lesions, routine treatment with orbital atherectomy prior to drug-eluting stent ...

Stent thrombosis is a rare but potentially life threatening complication of percutaneous coronary intervention (PCI). It develops when a blood clot blocks blood flow through your stent. A coronary ...

Results from the large-scale randomized ECLIPSE trial found that a lesion preparation strategy of routine orbital atherectomy had similar outcomes compared with conventional balloon angioplasty prior ...